STUDY QUESTION: How does the human oocyte transcriptome change with age and ovarian reserve?
Introduction
The developmental competence of an oocyte is its ability to sustain embryonic development until at least embryonic genome activation (EGA) (Braude et al., 1988; Vassena et al., 2011) . As no transcription occurs before EGA, the early steps of embryogenesis depend on mRNAs and proteins inherited from the oocyte.
During the last few decades, the average age of first-time mothers has increased world-wide (te Velde and Pearson, 2002) due to educational, social and economic factors. The negative correlation between age and fertility is well established in the scientific literature (Opinion, 2014) . In addition, a decrease in oocyte quality has been associated with advanced female age (Miao et al., 2009; Qiao et al., 2014) ; however, the underlying molecular mechanisms remain poorly understood (Keefe et al., 2015) .
It is also well established that as a woman age increases, the ovarian reserve diminishes. It is not clear whether the quantity of follicles left in the ovary is directly related to the quality of the oocytes they contain, on a per-oocyte basis. Currently, it is not possible to distinguish the effect of age versus diminishing ovarian reserve on oocyte quality (Eldar-Geva et al., 2005; Broekmans, 2009; Younis et al., 2015) .
Although part of the declining developmental competence associated with age can be assigned to increased meiotic errors (Armstrong, 2001) , other factors such as energy production and balance, metabolism, epigenetic regulation and cell cycle check-points are also likely to play important roles (Santonocito et al., 2013) . Gene expression studies in oocytes from several species indicate that the presence and activity of gene products involved in cell cycle regulation, spindle formation and organelle integrity may be altered in oocytes from older individuals. Oocytes from young versuss old mice contain approximately 5% differentially expressed transcripts (Pan et al., 2008) .The mammalian transcriptome consists of both protein coding and non-coding RNAs (ncRNAs) and the latter can be further divided into structural molecules, such as ribosomal RNA (rRNAs) or transfer RNAs (tRNAs) and regulatory molecules such as microRNAs (miRNAs), Piwi-interacting RNAs clusters (piRNAs-c), small interfering RNAs (siRNAs) and long non-coding RNAs (lncRNAs) (Lindberg and Lundeberg, 2010) .
The objective of the present study is to identify the coding and noncoding transcriptional profiles of in vivo matured MII human oocytes and evaluate their changes in relation to age and, independently, ovarian reserve.
Materials and Methods

Study population and ethical approval
A total of 36 in vivo matured MII oocytes from 30 healthy women recruited for oocyte donation were included in this study. Mean donor age was 27.8 ± 5.8 years old (range 20-35 years), with a mean antral follicular count (AFC) of 16.6 ± 10.4 (range 5-35 AFC). Mature MII oocytes were divided into four experimental groups of nine oocytes each based on the women's age and AFC: young women with high AFC (YH; age 21 ± 1 years and 24 ± 3 follicles), old women with high AFC (OH; age 32 ± 2 years and 29 ± 7 follicles), young women with low AFC (YL; age 24 ± 2 years and 8 ± 2 follicles) and old women with low AFC (OL; age 34 ± 1 years and 7 ± 1 follicles).
All oocyte donors had a BMI < 30, normal karyotype and no evidence of systemic or reproductive conditions. They were all non-carriers of clinically relevant alleles for cystic fibrosis and Fragile X. All donors were of Caucasian phenotype except for two (one east-asian and one hispanic) in group OL. All oocyte donors tested negative for HIV, sexually transmitted diseases and both hepatitis C and B. After warming, morphologically abnormal oocytes were excluded from the study.
The demographic and reproductive characteristics of participants are presented in Supplementary Tables SI and SII. Analysis of correlation (Spearman R = 0.752; P < 0.001) between AFC and cumulus-oocyte complexes (COCs) obtained indicate that AFC measurements reflect ovarian response of the woman and, indeed, ovarian reserve.
Ethical approval for the study was obtained by the local CEIC (Ethics Committee for Clinical Research). All women included in the study gave informed consent.
Ovarian stimulation
All women were stimulated with either follitropin alpha (Gonal ® , Merck Serono, Spain) or highly purified urinary hMG (Menopur ® , Ferring, Spain), with daily injections of 150-300 IU, as previously reported (Blazquez et al., 2014) . Pituitary suppression was performed with a GnRH antagonist (0.25 mg of Cetrorelix acetate, Cetrotide ® , Merck Serono, Spain) administered daily from Day 6 of stimulation (Olivennes et al., 1995) .
When three or more follicles of ≥18 mm of diameter were observed, final oocyte maturation was triggered with a dose of 0.2 of the GnRHa triptorelin (Decapeptyl ® , Ipsen Pharma, Spain). Oocyte collection was performed 36 h later by means of ultrasound-guided transvaginal follicular aspiration.
Oocyte collection and processing
Mature MII oocytes were vitrified on the day of retrieval using an open method and were warmed for the study according to standard procedure (Cryotop ® , Kitazato ® , BioPharma Co., Ltd; Japan) in five randomized groups, on different days during a period of 14 days, to minimize bias due to the handling process. After warming, oocytes were left for 2 h at 37°C and 6% CO2, to allow for reassembly of the metaphase plate (Bromfield et al., 2009) . The zona pellucida was removed using Pronase (Roche Diagnostics, Spain) and oocytes were immediately and individually placed in 45 μl of a Proteinase K-based lysis buffer (20 mM DTT, 0.5% SDS, 1 μg/μl proteinase K, 10 mM Tris.HCl, pH 7.4), incubated at 65°C for 15 min, and stored at −80°C until use (Gonzalez-Roca et al., 2010) .
RNA extraction for microarray and qPCR analysis
Total RNA extraction and amplification were based on the Pico-Profiling protocol and successive improvements for single oocyte use (GonzalezRoca et al., 2010; Vassena et al., 2011) . Pico-profiling faithfully amplifies the total RNA from as little as 10 somatic cells, or one MII oocyte, with a level of false positive signal in downstream analysis that is equivalent to that obtained without an amplification step. Briefly, RNA was purified from individual oocytes using RNA Clean XP bead suspension (Agencourt Bioscience, La Jolla, CA, USA) and eluted in 20 μl water. The RNA preparation was used for library preparation and amplification by Whole Transcriptome Amplification (WTA2, Sigma-Aldrich, Spain). SYBRGreen (Sigma-Aldrich, Spain) was added to the amplification reaction, which was performed in a CFX Real-time instrument (Bio-Rad, CA, USA) to monitor amplification yield. The amplification reaction was stopped when the SYBRGreen signal reached a plateau, and cDNA was purified and quantified on a Nanodrop ND-1000 spectrophotometer (Thermo-Fischer, MA, USA). A second round of amplification was performed from 10 ng of cDNA; 8 μg samples of cDNA (3.2 μg from the first round and 4.8 μg from the second) were subsequently fragmented by DNAseI and biotinylated by terminal transferase (GeneChip Mapping 250 K Nsp assay kit; Affymetrix, CA, USA). Biotin-labeled cDNA was hybridized on an Affymetrix GeneChip Human Transcriptome Array 2.0 (HTA 2.0). This GeneChip allows for analysis of more than 245 000 transcripts, covering 44 699 protein coding gene models and more than 40 000 transcripts covering 22 829 non-coding gene models. Moreover, to ensure uniform coverage of the transcriptome, HTA 2.0 was designed with approximately 10 probes per exon and four probes per exon-exon splice junction.
Data acquisition and normalization
Each array was hybridized, washed and scanned according to the manufacturer's specifications. The washing and staining was performed in a GeneChip ® Fluidics Station 450, and the scanning of the arrays was performed in a GeneChip ® Scanner 3000, according to Affymetrix specifications. The scanned images were transformed into intensities by GeneChip ® Command Console ® Software (AGCC, Affymetrix). RMA normalization and probe set signal summarization was applied using Expression Console software (Affymetrix) version 1.4.1.
Quantitative PCR
Array validation was performed by qPCR analysis using 5 ng (in triplicates) of the cDNA libraries previously constructed and hybridized. Selected transcripts were quantified by SYBRgreen fluorescence (Bio-Rad) using a CFX Real-Time PCR system (Bio-Rad). Baseline correction, threshold setting and relative expression were performed using the automatic calculation of the CFX Manager Software (Bio-Rad). The software includes algorithms generated to analyze gene expression results using multiple reference genes (Vandesompele et al., 2002) . Actin B (ACTB), ubiquitin C (UBC) and DNA methyltransferase-1 (DNMT1) were used as normalizers (Supplementary Table SIII) .
Statistical analysis
Principal Component Analysis (PCA) was applied to assess the distribution of the samples studied. For microarray data, statistical analysis was performed using the Transcriptome Analysis Console (TAC, v3.0.0.466) (Affymetrix) applying One-Way Between-Subject ANOVA (unpaired) and False Discovery Rate (FDR) based on Benjamini-Hochberg Step-Up (Benjamini and Hocheberg, 1995) . The FDR was fixed as FDR < 0.05 to retrieve results. Both linear regression and a pairwise comparison (P < 0.05, with 2-fold changes) were used to analyze expression differences among groups. To generate Venn diagrams, we used Venny's on-line (http://bioinfogp.cnb. csic.es/tools/venny/index.html) (Oliveros, 2007-15) . For qPCR validation, we performed One-Way Between-Subject ANOVA.
Results
Quality control analysis
In order to identify grouping of samples and technical bias, we carried out principal component analysis (PCA) to determine the effect of key variables (oocyte experimental conditions) on the observations (gene expression measurements), and to simplify the analysis and visualization of multidimensional datasets. PCA analysis did not reveal any obvious clustering, according to their biology or the RNA extraction, cDNA amplification or hybridization batches ( Supplementary Fig. S1 ).
For quality control (QC) of the arrays, density plots of log-intensity distribution of each array were performed to compare arrays and identify outlier arrays. One sample from group YL (D10.1) was found to be an outlier and removed from further analysis.
In addition, box-plots representing Relative Log Expression (RLE) values were computed for each probe set by comparing the expression value on each array against the median expression value for that probe set across all arrays in a dataset ( Supplementary Fig. S2 ) showing similar (but not identical) results, as expected.
Sibling oocyte variability
Determination of sibling oocyte variability was not an original objective of our study. However, the inclusion of two sibling oocytes for six of the donors (D13, D14 and D15 from YL group; D17 from YH; finally, D26 and D30 from OH group) allowed for a degree of intra-donor analysis. In order to analyze variability between oocytes from the same donor and donation cycle, we focused on hierarchical clustering of individual oocytes in the age and AFC comparisons, and recorded the distance between siblings in the context of the group. Age comparison revealed that four sibling pairs out of six (D13, D14, D15, D26) were separated when clustered by differential expressed genes, while only one sibling pair (D30) showed separation when clustered by AFC ( Fig. 1 ).
Differentially expressed transcripts in relation to age and/or ovarian reserve
In order to determine the effect of age on the human oocyte transcriptome, we compared oocytes from both young groups (YL + YH) to oocytes from both old groups (OL + OH) independently from the ovarian reserve. We detected 86 differentially expressed transcripts, including 17 mRNA and 69 ncRNAs (6 pre-miRNA, 17 piRNAs-c, 38 lncRNA (including 16 lncRNA and 22 long-intergenic RNA (lincRNA)) and other eight structural RNA molecules) (Fig. 1A , Table I ). A set of five miRNA (ENSG00000221162, hsa-mir-220b, ENSG00000239174, hsa-mir-4262 and hsa-mir-1260a) were increased in old group (OL + OH), while piRNAs-c and lncRNAs appeared mostly increased in young group (YH + YL).
To analyze the effect of AFC, we performed comparison of low (YL + OL) versus high (YH + OH) ovarian reserve independently from age. We detected 22 mRNA and 55 ncRNAs (4 pre-miRNA, eight piRNAs-c, 27 lncRNA (including 11 lncRNA and 16 lincRNA) and other 16 structural RNA molecules) showing differential expression (Fig. 1B , Table I ). From the differentially regulated transcripts, more than 60% were increased in the high AFC group compared with low AFC group.
While mRNAs and pre-miRNAs represented less than 30% and 10% of differentially expressed transcripts, respectively, lncRNAs and other structural RNA molecules represented more than 60% of differentially expressed transcripts. For example, we identified four Piwiinteracting RNAs clusters (piRNAs-c) increased in the high AFC groups (YH and OH) (piR-54999, piR-43765, piR-57434, piR-55000) and one increased piRNAs-c in young groups (YH + YL) (piR-54967).
When comparing both analysis groups (age and ovarian reserve), 17 transcripts (6 mRNA, one pre-miRNA, seven lncRNA and other three structural RNA molecules) were differentially expressed. Five of them (3 mRNA, one lncRNA and one structural RNA) were increased and three (1 mRNA (ANXA5) and two lncRNA) were decreased in oocytes from older women with low ovarian reserve (including Proline-Rich Gamma-Carboxyglutamic Acid Protein 1 (PRRG1), Immunoglobulin Heavy Variable 3-38 (IGHV3-38), Immunoglobulin Heavy Variable 3/OR16-9 (IGHV3OR16-9)), three increased in oocytes from younger women with high ovarian reserve (including one mRNAs (DUXAP10), two lncRNA), and one pre-miRNA was decreased in oocytes from older women with high ovarian reserve (hsa-mir-220b). In addition, RNY5, a member of Y RNA gene family (required for DNA replication), was increased in OL group compared with young groups (YH or YL) regardless of AFC and in old (OH + OL) and low AFC (YL + OL) groups, regardless of AFC and age, respectively (Supplementary File I).
In order to identify specific targets depending of both age and AFC, we compared all groups concomitantly. Strikingly, there was little Figure 1 Heat maps for the differentially expressed genes (>|2| fold change; P < 0.05) when age (A, white: young; gray: old) or AFC (B; white: high; gray: low) were compared and hierarchical clustering to analyze similarities between individualized samples. The name of the samples is indicated at the bottom of the cluster lines; sibling oocytes are indicated with equal dots of the same color. The color in the heat map (red to green scale) corresponds to relative transcript abundance. Different kinds of transcripts are represented as follows in the left vertical line: orange: messenger RNAs (mRNAs); pink: structural RNA; purple: precursors of microRNAs (pre-miRNAs); yellow: Piwi-interacting RNAs clusters (piRNAs-c); pale blue: longintergenic non-coding RNAs (lincRNAs); and dark blue: long non-coding RNAs (lncRNAs). The smear appearing in the central part of panel A, corresponds to 14 probes for piRNA-c that showed the same fold change among all the samples analyzed. Continued overlap of differentially expressed genes across groups. From this comparison, 198 unique genes were differentially expressed among the groups (Fold change 2, ANOVA P-value < 0.05; Fig. 2 , Table II and  Supplementary Table SIV) . The 198 genes were composed by 30 mRNA and 168 ncRNA. In comparison with the rest of the groups, Group YH showed increased differential expression of two ncRNAs, RP11-47P18.1 and krtap6-1 (Fig. 2A) . In Group OH, we detected differential upregulation of the ncRNA U78793 (Fig. 2B) . Group YL showed differential downregulation of the ncRNA transcript ENSG0000023917 (Fig. 2C) . Finally, Group OL presented a set of five differentially regulated transcripts (Fig. 2D) , consisting of one less abundant ncRNA (NONHSAG038790.2), two increased mRNAs (IGHV3-38 and IGHV3OR16-9) and two less abudant mRNAs (ANXA5 and SPATC1L). In order to determine the biological relevance of the differentially expressed transcripts, we have applied Gene Ontology (GO) analysis through TAC software to look for the presence of certain gene pathways or targets over-represented in the four cohorts. However, due to the low number of differentially expressed mRNAs, the GO analysis was inconclusive.
Array validation
A total of 22 coding transcripts were chosen for array validation by qPCR (Supplementary Table SIII) in all samples: seven of them as putative housekeeping genes (Actin B (ACTB), DNA methyltransferase-1 (DNMT1), phosphoglycerate kinase-1 (PGK1), proteasome subunit beta 5 (PSMB5), succinate dehydrogenase complex flavoprotein subunit A (SDHA), ubiquitin C (UBC), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ)) and 15 more predicted to be differentially expressed in at least one group (see Supplementary Table SIII for details). We were unable to amplify two of the transcripts by qPCR (PSMB5 and RNY5). After applying algorithms (geNORM, Vandesompele et al., 2002) to determine expression stability on the seven selected housekeeping candidates, three transcripts presented a coefficient of variation (CV) < 0.25 and M value < 0.5, indicating that they could be used as homogeneous reference genes (HRGs: ACTB, UBC, DNMT1). Thus, 17 coding transcripts were used to validate arrays (Fig. 3) . Box-plot analysis was used to represent the distribution of data from array (RMA) and the data 
Discussion
We report here for the first time the transcriptional profile of several (n = 36) single in vivo matured human oocytes from healthy, and fertile women of reproductive age. Our unique dataset allows for the generation of transcriptomic data that are as close as possible, giving current ethical and technical restrictions, to that of ovulated oocytes in a naturally cycling ovary. Our main finding is that age and ovarian reserve have an independent effect on the MII oocyte transcriptome. Although this was not the goal of the study, the presence of sibling oocytes in our dataset (six women contributed two oocytes each to the study) allowed us to explore the relationship of individual oocytes from the same woman on age and AFC comparisons. While the sibling oocytes did cluster together in the AFC comparison, they mostly clustered apart in the age comparison. This might indicate that transcripts that vary in their expression with AFC might be more conserved in their expression among sibling oocytes while those that vary with age might have a less conserved expression pattern among sibling oocytes.
It should also be kept in mind that, although all of the oocytes were from fertile donors, even in the best cases, no more than 30% of all fertilized oocytes will go on to develop into healthy offspring, and it is likely that there are significant inter-oocyte variations, as previously reported (Vassena et al., 2011) .
Classically, transcriptomic analysis of oocytes has focused on mRNA and their role in oocyte maturation and embryo development (Kocabas et al., 2006) . However, recent reports identified almost 10 000 ncRNAs at different stages of human preimplantation development, indicating that they might represent an important new level of regulation of early development and suggesting they should be present in oocytes as well (Xue et al., 2013; Yan et al., 2013) . To date, only a small fraction of these ncRNAs have functional annotations, particularly for human oocytes. There are very few reports on the human oocyte transcriptome (Labrecque and Sirard, 2014) , mostly obtained from oocytes from older women and infertile assisted reproduction patients. Although our manuscript is not the first one to report ncRNA expression in human oocytes, the aim of our work was to compare intensity of expression among oocytes from women of different ages and different AFC. As all our samples were oocytes, we did not expect to see any significant overlap of differentially expressed transcripts across developmental stages. Nevertheless, the recent work of Qiu and colleagues (Qiu et al., 2016) , reported a set of human transcripts containing 464 lncRNAs and 759 mRNAs that correlated with the oocyte stage. None of these 1223 human transcripts were differentially expressed in our dataset, indicating that the donor oocytes did not undergo overall changes in their transcriptomic profile.
Previous reports analyzing global gene expression profiles of mature MII oocytes which did not fertilize after IVF-ICSI from younger (<36 years) and older (>37 years) women identified several hundred differentially expressed genes in relation to age, involved in several cellular processes such as cell cycle regulation, cytoskeletal and chromosomal structure, energy pathways, transcription control, and stress response (Steuerwald et al., 2007; Fragouli et al., 2010; Grondahl et al., 2010) . However, it has been reported that the proportion of poor quality oocytes (te Velde and Pearson, 2002) increases with age, ranging from 50% at 20 years of age to 95% at 35 years of age (Eldar-Geva et al., 2005) .
In our case, when age groups were compared, from a total of 86 differentially expressed transcripts, we detected 17 differentially expressed mRNAs (HIST2H2AC, SPCS2, MAGEE-1, ANXA5, CLP5, GEM, PRRG1, STKY1, ARLG1P4, SMUG1, IGHV3-35, IGHV3-36, IGHV3-66, PFAS, ZSCAN22, PROCR and DUXAP10). This difference in results could be explained by the fact that in our study we used in vivo matured MII oocytes from healthy donors (<35 years) that did not undergo fertilization, whereas other reports (Steuerwald et al., 2007; Fragouli et al., 2010; Labrecque and Sirard, 2014) have used oocytes after unsuccessful fertilization. In these cases, the oocytes inevitably underwent in-vitro aging since fertilization is checked at least 16 h post-fertilization and, possibly, there was a paternal RNA cargo from the injected spermatozoon.
Among the mRNAs differentially expressed by ovarian reserve, six were also differentially expressed with age. Two of them, ANXA5 and DUXAP10, were increased in oocytes from young (<26 y.o.) women with high AFC (>20). ANXA5 is a calcium-dependent phospholipid binding protein that inhibits phospholipase A2 and protein kinase C (PKC) and presents has calcium channel activity (Arispe et al., 1996) . PKC has been related to oocyte activation in different animal models (Halet, 2004) . In Xenopus oocytes, a wave of PKC activation accompanies the calcium spikes after fertilization (Larabell et al., 2004) , and age 21 ± 1 years and 24 ± 3 follicles) group versus the other three groups, (B) Old with High AFC (OH; age 32 ± 2 years and 29 ± 7 follicles) group versus the other three groups, (C) Young with Low AFC (YL; age 24 ± 2 years and 8 ± 2 follicles) group versus the other three groups and (D) Old with Low AFC (OL; age 34 ± 1 years and 7 ± 1 follicles) group versus the other three groups.
activators of PKC are able to trigger cortical granule exocytosis (Bement and Capco, 1989) . Moreover, ANXA5 has been implicated in regulating Cystic fibrosis transmembrane conductance regulator (CFTR) function and intracellular trafficking in Xenopus oocytes (Faria et al., 2011) . We hypothesize that ANXA5 could have a role in maintaining meiosis arrest before fertilization in human oocytes as well. No function has yet been established for the pseudogene DUXAP10, although the DUXA homeobox gene family is expressed in early embryos and has recently been proposed to be involved in the control of gene expression after EGA (Madissoon et al., 2016) . How DUXAP10 transcripts could have a role during the maternal-to-zygote transition and participate in correct early embryo development should be studied further.
SPCS2 and PRRG1 were increased in oocytes in older women with low AFC (<10). SPCS2 is a microsomal signal peptidase of the minor spliceosome, involved in general mRNA processing, whose defects can lead to tissue-specific consequences (Argente et al., 2014) ; PRRG1 is a calcium ion binding protein. As fertilization is followed by calcium release, resumption of meiosis and mRNA processing until EGA, these transcripts could be potential markers of oocyte quality.
Among the 22 differentially expressed mRNAs identified when the effect of AFC was analyzed independently from age, Fidgetin (FIGN) was increased in oocytes from women with low AFC, and particularly in the OL group. (FIGN) has been suggested to be a microtubule-severing enzyme (Sharp and Ross, 2012) and its overexpression in cultured cells results in the destruction of cellular microtubules (Zhang et al., 2007) . FIGN could represent a marker of developmental competence in oocytes, as the proportion of oocytes with genetic abnormalities increases with female aging and low AFC (Grande et al., 2014) .
The remaining differentially expressed genes were ncRNA, regulators of post-transcriptional events and, in particular, important mediators of gene expression (Kaikkonen et al., 2011) . Increasing evidence for regulatory roles of ncRNAs during development has been Figure 3 Validation of HTA 2.0 array by qPCR using the same RNA samples. Box-plot analysis of log-intensities expression from the array (i) and gene expression profiles by qPCR (ii) of the selected genes was measured in individualized RNA extractions and amplification from human oocytes. All qPCR data is represented as ΔCq value (delta quantification cycle) (Cq(target)/Cq (HRGs)).
described (Dinger et al., 2008) . Since more than 70% of differential expressed genes in our study were ncRNAs, a relevant role in human oocyte and early embryo biology is strongly suggested.
A set of piRNAs-c were differentially expressed in relation to AFC. piRNAs have been described to act at both the epigenetic and posttranscriptional levels in gene silencing of retrotransposons and other genetic elements in both spermatogenesis (Siomi et al., 2011) , and oogenesis (Roovers et al., 2015) . However, the significance of finding a set of piRNAs-c differentially regulated related to AFC is unknown.
miRNAs, another class of ncRNAs which generally act by downregulating specific mRNAs were also found to be differentially expressed. In particular, the precursor form of miRNA1260a and miR4262 were increased in the older groups (OL + OH). Interestingly, one of the bioinformatically predicted targets of miR1260a (among 7493 annotated in www.microRNA.org) is argonaute (AGO1). Argonaute proteins bind different classes of small RNA (e.g. miRNA and piRNAs) and mediate mRNA cleavage or translation inhibition. Obviously, deregulation of such a central player could affect oocyte developmental competence in a major way (Wang et al., 2012) .
Another group of ncRNA found to be differentially expressed in our study were lncRNAs. Many lncRNAs act as key regulators of transcriptional and translational mechanisms (Cao, 2014) . Our results indicate that 33 lncRNA out of 68 ncRNA and 27 lncRNA out of 55 ncRNAs were differentially expressed when comparing age and AFC, respectively. These results suggest a relevant role of lncRNAs in controlling oocyte quality in terms of transcriptional content and, in consequence, their ability to promote correct transcriptional and transductional processes during the maternal-to-zygote transition. For instance, oocytes obtained from young women with low AFC exclusively presented 13 (5 increased and 8 decreased) and 19 (11 increased and 9 decreased) differentially expressed lncRNAs, when compared with those oocytes from young women with high AFC or old women with low AFC, respectively. We noticed that lncRNA lncTMEM155-3:1 and NR_028335 were increased and decreased, respectively, when comparing the YL group with the OL group. Although the mechanisms of action of lncRNA are poorly understood in general (and particularly in the oocyte) and its functional characterization is a challenging task, we find it suggestive that lncRNA lncTMEM155-3:1 is located at the 3′UTR of ANXA5 gene. As discussed above, given that ANXA5 was found increased in oocytes from young women with high AFC, we hypothesize that ANXA5 and lncRNA lncTMEM155-3:1, could both act as a negative regulators of each other.
Conversely, lncRNA NR_028335 could be a positive regulator of METTL16, as we have observed lncRNA NR_028335 decreased in YL (compared to OL) while METTL16 was increased in oocytes of old women, regardless of AFC.
A decade ago, Vallée and colleagues (Vallee et al., 2006) set out to identify evolutionarily conserved genes expressed in oocytes using multi-species cDNA microarray (mouse, bovine and Xenopus); 268 transcripts were identified as both conserved and preferentially expressed in oocytes of all three species. Recently, the same group (Sylvestre et al., 2013) compared the human oocyte transcriptome to an oocyte-enriched subset of mouse, bovine and frog (Xenopus laevis) transcripts. Their study revealed that, at the transcriptional level, bovine/human similarity was greater than mouse/human or frog/ human similarities. In addition, a high level of conservation, in Xenopus, Mus and Bos, relative to humans, was found in genes involved in early embryonic development. However, none of these transcripts have been detected as differentially expressed in our study.
In 2004, Hamatani and colleagues (Hamatani et al., 2004) described how age could determine alterations of gene expression patterns in mouse oocytes. Mature oocytes were collected from 5-to 6-week-old mice and compared to those collected from 42-to 45-week-old mice, and about 5% of the expressed transcripts showed significant changes in expression. Unfortunately, there is no clear association between mice and human aging, making it difficult to compare side by side these results to our data.
In conclusion, our study provides new insights into the biological link between age and ovarian reserve on the ncRNAs transcriptome, indicating how these two variables independently affect the human oocyte transcriptome. The results have implications for the search of oocyte quality markers and for the (re)interpretation of existing datasets. The observed changes are in turn that are expected to alter the translational regulation of early human embryogenesis and suggest an important role for ncRNAs in human oocyte biology. Further analysis of ncRNA function would reveal a more complete landscape of pathways defining developmental competence of the human oocyte.
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